Hangzhou, China – October 2025 — Singclean Medical, a leading developer and manufacturer of absorbable biomaterials, will participate in MEDICA 2025 from November 17th to 20th at the Messe Düsseldorf, Germany, located at Hall 16 / H67-3.

Since its establishment in 2002, Singclean Medical has been dedicated to advancing the field of absorbable biomaterials, offering diversified medical innovation solutions including medical aesthetics, natural skincare, hyaluronic acid gels, absorbable hemostatic materials, and in vitro diagnostic reagents. Today, Singclean’s products are registered in over 50 countries and trusted by healthcare professionals and distributors across 80+ countries and regions.
With a strong commitment to quality, innovation, and global collaboration, Singclean invests over 10% of its annual revenue into research and development. The company has evolved into a comprehensive high-tech enterprise integrating R&D, manufacturing, and international marketing, with partnerships established with more than 330 global companies.
At MEDICA 2025, Singclean will present its latest generation of biomaterial solutions, designed to meet the growing global demand for safe, effective, and innovative medical products. More importantly, this exhibition provides an opportunity for Singclean to connect face-to-face with partners and clients, explore new business collaborations, and discuss customized solutions tailored to local markets.
Guided by its philosophy — “Beyond Products, We Build Partnerships” — Singclean Medical looks forward to creating long-term, mutually beneficial relationships with global partners, strengthening its role as a trusted contributor to the global healthcare industry.
Event Details:
Venue: Messe Düsseldorf, Germany
Date: November 17–20, 2025
Booth: Hall 16 / H67-3
For partnership inquiries or meeting arrangements, please contact support@singclean.net.
-
singclean | 2025-10-28
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2025-10-28
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2025-10-28
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.